Bioceres Crop Solutions (NASDAQ:BIOX) Given New $7.00 Price Target at Oppenheimer

Bioceres Crop Solutions (NASDAQ:BIOX - Get Free Report) had its price objective cut by Oppenheimer from $8.00 to $7.00 in a research note issued to investors on Tuesday,Benzinga reports. The firm currently has an "outperform" rating on the stock. Oppenheimer's price target points to a potential upside of 62.79% from the company's current price.

A number of other research analysts have also weighed in on the stock. Canaccord Genuity Group dropped their price target on shares of Bioceres Crop Solutions from $7.00 to $6.50 and set a "buy" rating on the stock in a research report on Thursday, February 13th. Lake Street Capital dropped their target price on shares of Bioceres Crop Solutions from $13.00 to $8.00 and set a "buy" rating on the stock in a research report on Friday, February 7th. Four research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, the company has an average rating of "Buy" and a consensus target price of $8.63.

Bioceres Crop Solutions Stock Down 1.1 %

NASDAQ BIOX traded down $0.05 on Tuesday, reaching $4.30. The company had a trading volume of 85,141 shares, compared to its average volume of 168,315. The company has a quick ratio of 0.96, a current ratio of 1.33 and a debt-to-equity ratio of 0.43. The company's fifty day moving average is $4.39 and its 200 day moving average is $5.83. Bioceres Crop Solutions has a 52-week low of $3.51 and a 52-week high of $13.18. The stock has a market capitalization of $269.66 million, a P/E ratio of 215.11 and a beta of 0.60.

Hedge Funds Weigh In On Bioceres Crop Solutions

Institutional investors have recently added to or reduced their stakes in the stock. Fourth Sail Capital LP raised its position in Bioceres Crop Solutions by 16.6% in the fourth quarter. Fourth Sail Capital LP now owns 3,698,961 shares of the company's stock worth $22,490,000 after acquiring an additional 527,859 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in shares of Bioceres Crop Solutions by 135.0% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 752,335 shares of the company's stock worth $4,574,000 after purchasing an additional 432,206 shares during the period. Long Focus Capital Management LLC raised its holdings in shares of Bioceres Crop Solutions by 130.7% in the 4th quarter. Long Focus Capital Management LLC now owns 744,748 shares of the company's stock worth $4,528,000 after purchasing an additional 421,931 shares during the period. Ballast Asset Management LP lifted its stake in Bioceres Crop Solutions by 23.5% in the fourth quarter. Ballast Asset Management LP now owns 431,887 shares of the company's stock valued at $2,620,000 after purchasing an additional 82,187 shares during the last quarter. Finally, JPMorgan Chase & Co. grew its holdings in Bioceres Crop Solutions by 49.3% during the third quarter. JPMorgan Chase & Co. now owns 89,973 shares of the company's stock valued at $708,000 after purchasing an additional 29,693 shares during the period. Institutional investors own 17.68% of the company's stock.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.